1. MAGE-A Antigens and Cancer Immunotherapy
   Paul Zajac et al, 2017, Frontiers in Medicine CrossRef
2. TGF- β induced epithelial–mesenchymal transition in an advanced cervical tumor model by 3D printing
   Y Pang et al, 2018, Biofabrication CrossRef
3. Current salivary biomarkers for detection of human papilloma virus‐induced oropharyngeal squamous cell carcinoma
   Drew H. Smith et al, 2021, Head & Neck CrossRef
4. MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer
   Stefan Hartmann et al, 2018, Clinical Oral Investigations CrossRef
5. CD44 and associated markers in oral rinses and tissues from oral and oropharyngeal cancer patients
   Erin R. Cohen et al, 2020, Oral Oncology CrossRef
6. Prognostic Value of Melanoma-Associated Antigen-A (MAGE-A) Gene Expression in Various Human Cancers: A Systematic Review and Meta-analysis of 7428 Patients and 44 Studies
   Manish Poojary et al, 2020, Molecular Diagnosis & Therapy CrossRef
7. Co‐expression pattern of SLC transporter genes associated with the immune landscape and clinical outcomes in gastric cancer
   Yue Zhang et al, 2023, Journal of Cellular and Molecular Medicine CrossRef
8. Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer
   Stefan Hartmann et al, 2018, Journal of Cranio-Maxillofacial Surgery CrossRef
9. Effective early detection of oral cancer using a simple and inexpensive point of care device in oral rinses
   Elizabeth J Franzmann et al, 2018, Expert Review of Molecular Diagnostics CrossRef
10. Immunomodulatory aspects in the progression and treatment of oral malignancy
    Nobuo Kondoh et al, 2019, Japanese Dental Science Review CrossRef
11. The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells
    Yanzhe Gao et al, 2018, Scientific Reports CrossRef
12. Antibody response against cancer‑testis antigens MAGEA4 and MAGEA10 in patients with melanoma
    Kadri �unap et al, 2018, Oncology Letters CrossRef
13. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation
    Aaron Chen et al, 2020, PLOS ONE CrossRef